Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
Artificial intelligence (AI)-powered large language models, such as ChatGPT, are increasingly used by the public for health information. The reliability of such novel AI-tools in providing credible polycystic ovary syndrome (PCOS) information/advice requires investigation. Healthcare professionals involved in PCOS care (n = 43 from 14 countries) used a 5-point Likert scale to evaluate ChatGPT-generated responses to frequently asked questions about PCOS against the corresponding...
Published on: Thu, 16 Apr 2026 06:00:00 -0400
Authors: Sandro Graca, Alexander Dallaway, Folashade Alloh, Harpal S Randeva, Chris Kite, Ioannis Kyrou,
CONCLUSION: Our findings suggest quercetin alleviates PCOS-related ovarian fibrosis by modulating gut microbiota and promoting SCFA production. This research highlights a novel mechanism for treating PCOS-related ovarian fibrosis, warranting further investigation.
Published on: Thu, 16 Apr 2026 06:00:00 -0400
Authors: Xi He, Peiyin Yang, Shuxuan Zhang, Kailu Liu,
Polycystic ovary syndrome (PCOS) is characterized by lipid metabolism disorders and oxidative stress. Dysregulated lipid metabolism and oxidative stress are key drivers of chronic inflammation, notably through M1 macrophage polarization within the ovarian microenvironment. The aim of our study was to identify key metabolic regulators involved in PCOS pathogenesis. We analyzed the intersection of lipid metabolism-related genes and significantly upregulated genes from two GEO datasets (GSE226146...
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: Hui Yang, Shuang Zhao, Lei Yang, Xinxin Quan, Xue Xue, Yu Liu, Kejie Yao, Rongxiang Wang, Qin Liu, Kang Zou, Qingling Zhu, Lun Suo, Lihua Sun,
CONCLUSION: OFS alleviates PCOS-like phenotypes in a microbiota- and bile acid-dependent manner and enhances ovarian aromatization. These findings move beyond descriptive bile acid alterations in PCOS by providing functional evidence that dietary fiber-induced bile acid remodeling is associated with modulation of ovarian steroidogenic regulation.
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: Yuhui Wang, Xitong Liu, Zhi Li, Ahui Kang, Yixuan Bai, Yang Wang, Yan Liu, Chujun Zhang, Jiaqi Yang, Qingqing Cai, Yi Feng, Huan Yi, Mengyu Zhang, Feifei Zhang, Haiou Liu, Congjian Xu,
Endocrine disruption, infertility, anovulation, impaired cyclicity, and ovarian damage are complications of polycystic ovary syndrome (PCOS). Herein, we explore the potential role of Costus speciosus extract in letrozole-induced polycystic ovary syndrome in female rats. For PCOS induction, letrozole 1.0 mg/kg body weight was given orally for 90 days. Four groups of female rats were randomly assigned. Group 1, the control, was orally administered distilled water. Group 2 received 300 mg/kg Costus...
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: R Elmazoudy, A Alqosaibi, M Alnamshan, I Al-Dhuayan, N F AlAhmady, A Alsayyah, H A Alhawaj,
CONCLUSION: Individuals within the lean PCOS group exhibited elevated AMH levels and demonstrated a more favorable response to rFSH stimulation. Consequently, the lean PCOS group yielded more retrieved oocytes, while necessitating lower doses of rFSH stimulation compared to the obese PCOS group.
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: Radan Muharam, Yuannita Ika Putri, Muhammad Ikhsan, Edward Christopher Yo, Alisha Nurdya Irzanti, Achmad Kemal Harzif, Mila Maidarti, Budi Wiweko, Andon Hestiantoro, Eva Suarthana, Togas Tulandi,
CONCLUSION: The results indicate that the addition of vitamin E to the letrozole-tamoxifen-estradiol protocol might be associated with improved ovulatory outcomes in women with PCOS. Nevertheless, no significant effect on pregnancy rates was observed. These findings highlight the potential adjunctive role of vitamin E in ovulation induction among women with PCOS, although further large-scale randomized trials are needed to confirm its clinical relevance (number registration:...
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: Athar Rasekh Jahromi, Nader Sharifi, Mohamad Karimi Javad, Vahid Rahmanian,
CONCLUSION: metformin and levothyroxine synergistically improve PCOS-related MAFLD by restoring autophagy and metabolic-endocrine balance. System-level and docking analyses support autophagy regulation as a key therapeutic mechanism, highlighting the potential role of levothyroxine in modulating autophagy.
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: Sameeah Mejbel Hamad Algenabi, Anwar Nather Seiwan, Maha Hussein Hashem Sabra, Doaa I Mohamed, Lobna Fouad Abd ElAziz Bassyouni, Dalia Alaa El-Din Aly El-Waseef, Samar F Ezzat, Omnyah A El-Kharashi, Hanaa F Abd El-Kareem, Hyfa A Alzahrani, Fawzyah Obeedallah Albaldi, Ahmed Shokry Elharoun, Mansour Altayyar, Amal Fahmy Dawood, Hebatallah H Abo Nahas, Ahmed Abdel-Salam M Elmelegy,
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and reproductive disorder affecting 11-13% of women worldwide. It is defined by key clinical signs like elevated androgen levels and infrequent ovulation. PCOS, the most common endocrine cause of infertility in women of reproductive age, is often linked to insulin resistance, obesity, and other metabolic issues. It is closely associated with imbalances in the metabolism of glucose and lipids. Crucially, PCOS interacts with disorders of...
Published on: Wed, 15 Apr 2026 06:00:00 -0400
Authors: Rui Zhu, Xinzhe Wang, Jingyun Ma, Xiuwen Shi, Yizhu Zhang, Jing Jin, Huifang Zhou,
No abstract
Published on: Tue, 14 Apr 2026 06:00:00 -0400
Authors: Wei Guo, Lixue Chen, Zi Yang, Linlin Wang, Hongping Wu, Rui Yang, Shuo Yang, Xiaoying Zheng, Hsun-Ming Chang, Xiumei Zhen, Jie Qiao, Rong Li,
CONCLUSION: The authors propose that expedited diagnosis of PCOS, attending to patients' mental health needs, personalized lifestyle modifications and education, and strategies to promote positive patient experiences may help to improve PCOS care.
Published on: Tue, 14 Apr 2026 06:00:00 -0400
Authors: Hayley Patrick, Liam McAlister, Ava Pourtousi, Jasmine Badesha, Selina L Liu, Suhaima Tunio, Kristin K Clemens,
No abstract
Published on: Tue, 14 Apr 2026 06:00:00 -0400
Authors:
CONCLUSION: Based on these findings, we concluded that body composition does not appear to be a determining factor for increased risk of depressive symptoms or poorer perceptions of QoL and HRQoL in women with PCOS.
Published on: Tue, 14 Apr 2026 06:00:00 -0400
Authors: Thalita Ponce, Patrícia Dos Santos Vigário, Cloyra de Paiva Almeida, Flávia Lucia Conceição,
CONCLUSION: The interaction between NETRGs and MRGs forms a "dual-engine" mechanism driving PCOS pathogenesis. This study proposed a novel diagnostic model and therapeutic targets (eg, DNase I and urolithin A), advancing precision medicine for PCOS.
Published on: Tue, 14 Apr 2026 06:00:00 -0400
Authors: Ning Huang, LuYun Lou,
CONCLUSIONS: Dietary pattern selection should be individualized according to metabolic phenotype, comorbidities, and adherence potential. Larger, longer, head-to-head trials measuring hard clinical outcomes are needed.
Published on: Tue, 14 Apr 2026 06:00:00 -0400
Authors: Amelia Caretto, Anna Zanardini, Giulio Frontino, Erika Pedone,